or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    ALXO F ALX Oncology Holdings Inc. 6.61
    TSBX F Turnstone Biologics Corp. 0.02
    APTO F Aptose Biosciences, Inc. -12.12
    STTK F Shattuck Labs, Inc. -10.07
    PRLD F Prelude Therapeutics Incorporated 0.86
    HOWL F Werewolf Therapeutics, Inc. 9.45
    ENLV F Enlivex Therapeutics Ltd. -12.35
    CLRB F Cellectar Biosciences, Inc. 0.32
    RLAY F Relay Therapeutics, Inc. -0.75
    TCRX F TScan Therapeutics, Inc. -3.28
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Cancer Immunotherapy Cancer Treatment Immunotherapy Medicine Biopharmaceutical Cell Therapy Immune System Immunotherapies Tumor Virotherapy Akseli Hemminki Antineoplastic Drugs Biology Cell Biology Non Small Cell Lung Cancer Oncolytic Virus Soft Tissue Sarcoma

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 12.11
    CANC D Tema Oncology ETF 9.79
    FBT D First Trust Amex Biotech Index Fund 7.71
    BBH D Market Vectors Biotech ETF 6.85
    MNTL D Tema Neuroscience and Mental Health ETF 4.48
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare BBH to MNTL Compare IDNA to BBH Compare IDNA to FBT

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 21 ALXO ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 20 RLAY Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 20 HOWL Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 19 RLAY Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 19 CLRB Q3 2024 Cellectar Biosciences Inc Earnings Call
        Nov 18 CLRB Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
        Nov 18 CLRB Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
        Nov 18 CLRB Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
        Nov 18 CLRB Earnings Scheduled For November 18, 2024
        Nov 16 STTK Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 CLRB Cellectar Biosciences Q3 2024 Earnings Preview
        Nov 15 STTK Shattuck Labs sees cash runway into 2027
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biopharmaceutical Medicine Acute Myeloid Leukemia Biotechnology Clinical Medicine Multiple Myeloma Myelodysplastic Syndrome Antineoplastic Drugs Cancer Immunotherapy Cancer Treatment Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Product Drugs Hematologic Malignancies Immunotherapies Immunotherapy Inflammation Janus Kinase Inhibitor
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags